Cytokine prestimulation as a gene therapy strategy: Implications for using the MDR1 gene as a dominant selectable marker

Blood

Volumn 89, Issue 1, 1997, Pages 146-154

  Blau, C Anthony ^a   Neff, Tobias ^a   Papayannopoulou, Thalia ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; NAVELBINE; PACLITAXEL; STEM CELL FACTOR; VINBLASTINE;

ANIMAL CELL; ARTICLE; CELL SELECTION; CONTROLLED STUDY; DNA TRANSFER; FEMALE; HEMATOPOIETIC STEM CELL; IMMUNOSTIMULATION; MARKER GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031020809     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.1.146.146_146_154     Document Type: Article

References (28)

1. Dunbar CE, Cottier-Fox M, O'Shaughnessy JA, Doren S, Carter C, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM, Leitman SF, Wilson WH, Cowan K, Young NS, Nienhuis AW: Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85:3048, 1995
2. Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN: Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342:1134, 1993
3. Sorrentino BP: Drug resistance gene therapy, in Brenner MK (ed): Gene Transfer; Scientific Advances and Clinical Developments. (in press)
4. Williams DA, Hsieh K, DeSilva A, Mulligan RC: Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow. J Exp Med 166:210, 1987
5. Corey CA, DeSilva AD, Holland CA, Williams DA: Serial transplantation of methotrexate-resistant bone marrow: Protection of murine recipients from drug toxicity by progeny of transduced stem cells. Blood 75:337, 1990
6. Sorrentino BP, Brandt SJ, Bodine D, Gottesman M, Pastan I, Cline A, Nienhuis AW: Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257:99, 1992
7. Hanania EG, Fu S, Roninson I, Zu Z, Gottesman MM, Deisseroth AB: Resistance to taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR1 transcription unit. Gene Ther 2:279, 1995
8. Spencer HT, Sleep SEH, Rehg JE, Blakley RL, Sorrentino BP: A gene transfer strategy for making bone marrow cells resistant to trimetrexate. Blood 87:2579, 1996
9. Podda S, Ward M, Himelstein A, Richardson C, de la FlorWeiss E, Smith L, Gottesman M, Pastan I, Bank A: Transfer and expression of the human multiple drug resistance gene into live mice. Proc Natl Acad Sci USA 89:9676, 1992
10. Molineux G, Migdalska A, Szmitkowski M, Zsebo K, Dexter TM. The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood 78:961, 1991
11. + colony-forming cell types in blood and marrow of baboons. Blood 80:920, 1992
12. Fleming WH, Alpern EJ, Ucbida N, Ikuta K, Weissman IL: Steel factor influences the distribution and activity of murine hematopoietic stem cells in vivo. Proc Natl Acad Sci USA 90:3760, 1993
13. Bodine DM, Seidel NE, Zsebo DM, Orlic D: In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood 82:445, 1993
14. Harrison DE, Zsebo DM, Astle CM: Splenic primitive hematopoietic stem cell (PHSC) activity is enhanced by steel factor because of PHSC proliferation. Blood 83:3146, 1994
15. Bodine DM, Seidel NE, Orlic D: Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood 88:89, 1996
16. Molineux G, Migdalska A, Haley J, Evans GS, Dexter TM: Total marrow failure induced by pegylated stem-cell factor administered before 5-fluorouracil. Blood 83:3491, 1994
17. Gottesman MM, Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385, 1993
18. Rowinsky EK, Donehower RC: Antimicrotubule agents, in Chabner BA, Longo DL (eds): Cancer Chemotherapy and Biotherapy: Principles and Practice. Philadelphia, PA, Lippencott-Raven, 1996, p 263
19. Sugimoto Y, Tsuruo T: DNA-mediated transfer and cloning of a human multidrug resistance gene of adriamycin-resistant my-elogenous leukemia K562. Cancer Res 47:2620, 1987
20. Doroshow JH: Anthracyclines and anthracenediones, in Chabner BA, Longo DL (eds): Cancer Chemotherapy and Biotherapy: Principles and Practice. Philadelphia, PA, Lippincott-Raven, 1996, p 409
21. Jones RJ, Wagner JE, Celano P, Zicha MS, Sharkis SJ: Separation of pluripotent haematopoietic stem cells from spleen colonyforming cells. Nature 347:188, 1990
22. Aran JM, Gottesman MM, Pastan I: Drug-selected coexpression of human glucocerebrosidase P-glycoprotein using a bicistronic vector. Proc Natl Acad Sci USA 91:3176, 1994
23. Berardi AC, Wang A, Levine JD, Lopez P, Scadden DT: Functional isolation and characterization of human hematopoietic stem cells. Science 267:104, 1995
24. Dancey JT, Deubelbeiss KA, Harker LA, Finch CA: Neutrophil kinetics in man. J Clin Invest 58:705, 1976
25. Cronkite EP, Fleidner TM: Granulocytopoiesis. N Engl J Med 270:1347, 1964
26. Massa G, Bogliolo G, D'Amore F: Hematopoietic precursor cells in mice treated with 4-demethoxydaunorubicin and doxorubi-cin. J Natl Cancer Instit 68:971, 1982
27. Blackett NM, Millard RE: Different recovery patterns of mouse haemopoietic stem cells in response to cytotoxic drugs. J Cell Physiol 89:473, 1976
28. Chaudhary PM, Roninson IB: Expression and activity of Pglycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66:85, 1991